Merck & Co., Inc. (MRK)

NYSE: MRK · Delayed Price · USD
93.08
0.77 (0.83%)
At close: May 27, 2022 4:03 PM
93.09
0.01 (0.01%)
After-hours:May 27, 2022 5:58 PM EDT

Company Description

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health.

The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines.

The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.

It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers.

The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV.

Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Merck & Co., Inc.
Merck & Co. Logo
CountryUnited States
Founded2000
IndustryPharmaceuticals
SectorHealth Care
Employees67,000
CEOKenneth Frazier

Contact Details

Address:
2000 Galloping Hill Rd
Kenilworth, New Jersey 07033-1310
United States
Phone908 740 4000
Websitemerck.com

Stock Details

Ticker SymbolMRK
ExchangeNYSE
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0000310158

Key Executives

NamePosition
Kenneth C. FrazierExecutive Chairman
Robert M. Davis J.D.President, Chief Executive Officer and Director
Caroline LitchfieldExecutive Vice President and Chief Financial Officer
Richard R. DeLuca Jr.Executive Vice President and President of Merck Animal Health
Dr. Dean Y. Li M.D., Ph.D.Executive Vice President and President of Merck Research Laboratories
David Michael WilliamsExecutive Vice President and Chief Information and Digital Officer
Peter DannenbaumVice President of Investor Relations
Jennifer L. ZacharyExecutive Vice President and General Counsel
Lisa LeCointe-CephasSenior Vice President and Chief Ethics and Compliance Officer
Jennifer MauerVice President of Global Communications

Latest SEC Filings

DateTypeTitle
May 26, 20228-KCurrent report
May 20, 2022SDSpecialized disclosure report
May 13, 2022PX14A6GNotice of exempt solicitation submitted by non-management
May 5, 20224Statement of changes in beneficial ownership of securities
May 5, 20224Statement of changes in beneficial ownership of securities
May 5, 20224Statement of changes in beneficial ownership of securities
May 5, 20224Statement of changes in beneficial ownership of securities
May 5, 20224Statement of changes in beneficial ownership of securities
May 5, 20224Statement of changes in beneficial ownership of securities
May 5, 20224Statement of changes in beneficial ownership of securities
View All SEC Filings